Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eran Broshy currently holds 60,204 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eran Broshy has been a net seller of TBPH stock. They have purchased $905.2K and sold $11.5M worth of shares.
Eran Broshy's most recent insider trade was on Nov 26, 2025, when they sold 14,000 shares at $20.00 per share.
Eran Broshy serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 72 insider transactions totaling $12.4M over their tenure at the company.
Eran Broshy holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Eran Broshy has shown a selling trading pattern, with $905.2K in total purchases and $11.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eran Broshy was on Jul 16, 2007, when they sold $1.6M worth of VTIV shares. This transaction involved 40,938 shares at $38.12 per share.
Eran Broshy currently owns 60,204 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eran Broshy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eran Broshy has 72 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Eran Broshy and 40,000+ other insiders.